PharmaPrimes is a leading Contract Research Organization (CRO) specializing in pharmaceutical testing, with a strong focus on Bioanalysis, Biological drugs testing, and Biosimilars. We are committed to delivering high-quality, precise, and reliable testing services that support the development and approval of innovative pharmaceutical products. In addition to our bioanalytical expertise, we also provide comprehensive pharmaceutical product development and QC testing for drug products, ensuring that all stages of development meet the rigorous standards required in today's dynamic pharmaceutical landscape.
Company Details
- Employees
- 16
- Founded
- -
- Address
- Sweifieh, Parkplaza,jordan
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- http://www.pharmaprimes.com
- Keywords
- Bioanalytical Testing, Biological Drug Testing, Biosimilar Testing, Pharmaceutical Research, Method Development and Validation, Clinical Trial Support, Quality Assurance and Control, R&D Services, Pharmaceutical products development.
- HQ
- amman
Pharmaprimes Laboratories Questions
Pharmaprimes Laboratories's website is http://www.pharmaprimes.com
Pharmaprimes Laboratories's LinkedIn profile is https://jo.linkedin.com/company/pharmaprimes-labs
Pharmaprimes Laboratories has
16 employees.
View email and phone details for 16
employees at Pharmaprimes Laboratories.
Pharmaprimes Laboratories's industry is
Research Services
Pharmaprimes Laboratories's top competitors are
Pharma International Company,
Chanelle Pharma,
Dar Al Dawa Development & Investment Co,
Pharmaprime,
Tabuk Pharmaceuticals Manufacturing Company,
Resonance Research Lab,
Hikma Pharmaceuticals,
Joswe Medical,
Pharmaceutical Research Unit,
Ms Pharma.
Pharmaprimes Laboratories's categories are Research Services
Pharmaprimes Laboratories's founding year is 2023
